Japan IR Japanese Corporate IR Information - Clear, Accessible

#COVID19

List of IR information related to "COVID19".

1 IR Posts

1 Companies

11 days ago Last Updated

1 IR Posts

4507 Shionogi & Co., Ltd.

2026/03/23

Additional Approval in Japan for the COVID-19 Antiviral Drug Xocova® for Prevention of COVID-19 Infection

Shionogi & Co., Ltd.'s anti-SARS-CoV-2 drug Xocova® obtained additional approval in Japan for post-exposure prevention of COVID-19. Impact on FY ending March 2026 earnings is minimal.

#Shionogi #NewDrugApproval #COVID19

#COVID19

Filters